New class of alkynyl glycoside analogues as tyrosinase inhibitors.
Bioorg Med Chem Lett
; 30(15): 127276, 2020 08 01.
Article
em En
| MEDLINE
| ID: mdl-32527455
ABSTRACT
A new series of alkynyl glycoside analogues were designed and synthesized from cheap and a commercially available sugar by introduction of various alkynyl and alkyl groups at C-1 and C-6 positions of the sugar ring. The inhibitory abilities of alkynyl glycosides were investigated in vitro on mushroom tyrosinase for the catalysis of l-Tyrosine and l-DOPA as substrates and comparing with arbutin and kojic acid. Non-terminal alkyne compound 2d showed excellent tyrosinase inhibitory activity (IC50 54.0 µM) against l-Tyrosine comparable to arbutin (IC50 1.46 mM) while 2b exhibited potent activities (IC50 34.3 µM) against L-DOPA higher than kojic acid (IC50 0.11 mM) and arbutin (IC50 13.3 mM). Kinetic studies revealed that compound 2d was a non-competitive inhibitor with the best Ki value of 21 µM and formed an irreversible receptor complex with mushroom tyrosinase. The SARs results showed that the type of alkyne and alkyl groups at position C-6 on sugar and the stereoisomer played an important role in determining their inhibitory activities. The potent activity of alkynyl glycosides identified in this study highlight the importance of this scaffold and these compounds are very modestly potent to the development of new class for tyrosinase inhibitor.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Monofenol Mono-Oxigenase
/
Alcinos
/
Inibidores Enzimáticos
/
Glicosídeos
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article